Loading insider details...
Latest Form 4 (Jun 16, 2026): Grant/Award of 30,000 PLSE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/Award | 30,000 | n/a |
| Jun 12, 2026 | Summit Therapeutics Inc. (SMMT) | Purchase | 3,810,000 | $49.99M |
| Jun 4, 2026 | Summit Therapeutics Inc. (SMMT) | Purchase | 100,000 | $1.46M |
| Jan 7, 2026 | Summit Therapeutics Inc. (SMMT) | Grant/Award | 11,232 | $98.4K |
| Oct 23, 2025 | Summit Therapeutics Inc. (SMMT) | Grant/Award | 266,808 | $5.00M |
| Sep 11, 2025 | Summit Therapeutics Inc. (SMMT) | Purchase | 333,394 | $5.89M |
| Aug 20, 2025 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/Award | 30,000 | n/a |
| Jun 2, 2025 | Summit Therapeutics Inc. (SMMT) | Exercise/Conversion | 74,545 | $196.8K |
| May 1, 2025 | Summit Therapeutics Inc. (SMMT) | Grant/Award | 1,040,000 | n/a |
| Apr 9, 2025 | Summit Therapeutics Inc. (SMMT) | In-the-Money Exercise | 3,985,055 | $6.30M |